TRIPODO, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 28.579
EU - Europa 11.138
AS - Asia 9.524
SA - Sud America 2.057
Continente sconosciuto - Info sul continente non disponibili 1.820
AF - Africa 315
OC - Oceania 82
Totale 53.515
Nazione #
US - Stati Uniti d'America 28.074
SG - Singapore 3.518
IT - Italia 2.786
RU - Federazione Russa 2.627
CN - Cina 2.334
BR - Brasile 1.519
FI - Finlandia 1.137
HK - Hong Kong 999
DE - Germania 915
VN - Vietnam 900
UA - Ucraina 681
PL - Polonia 669
GB - Regno Unito 582
IE - Irlanda 495
FR - Francia 434
JP - Giappone 348
BD - Bangladesh 319
SE - Svezia 251
CA - Canada 233
IN - India 199
KR - Corea 194
AR - Argentina 159
NL - Olanda 144
MX - Messico 122
TR - Turchia 108
CI - Costa d'Avorio 101
CO - Colombia 92
EC - Ecuador 91
IQ - Iraq 89
AT - Austria 82
AU - Australia 76
VE - Venezuela 68
ES - Italia 64
ID - Indonesia 61
RO - Romania 54
BE - Belgio 51
PK - Pakistan 49
ZA - Sudafrica 49
UZ - Uzbekistan 44
JM - Giamaica 42
MY - Malesia 41
MA - Marocco 37
PH - Filippine 34
SA - Arabia Saudita 34
IR - Iran 33
PY - Paraguay 33
KE - Kenya 30
CH - Svizzera 29
CL - Cile 29
CR - Costa Rica 29
EG - Egitto 28
NP - Nepal 27
UY - Uruguay 25
TW - Taiwan 22
AE - Emirati Arabi Uniti 21
PE - Perù 21
KZ - Kazakistan 19
DZ - Algeria 17
GR - Grecia 17
JO - Giordania 17
BO - Bolivia 16
TN - Tunisia 15
DO - Repubblica Dominicana 14
HN - Honduras 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
LT - Lituania 13
AZ - Azerbaigian 11
LB - Libano 11
TH - Thailandia 10
AL - Albania 9
GE - Georgia 9
KG - Kirghizistan 9
OM - Oman 9
RS - Serbia 9
TT - Trinidad e Tobago 9
BA - Bosnia-Erzegovina 8
BB - Barbados 8
BH - Bahrain 8
EE - Estonia 8
MD - Moldavia 8
PT - Portogallo 8
BY - Bielorussia 7
DK - Danimarca 7
ET - Etiopia 7
IL - Israele 7
LK - Sri Lanka 7
LV - Lettonia 7
NI - Nicaragua 7
PA - Panama 7
SN - Senegal 7
GT - Guatemala 6
SY - Repubblica araba siriana 6
EU - Europa 5
MN - Mongolia 5
QA - Qatar 5
KH - Cambogia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BN - Brunei Darussalam 3
GY - Guiana 3
Totale 51.639
Città #
Ashburn 3.327
Fairfield 3.232
Singapore 2.375
San Jose 1.840
Woodbridge 1.575
Houston 1.298
Seattle 1.285
Wilmington 1.268
Cambridge 1.187
Chandler 1.109
Hong Kong 956
Ann Arbor 681
Zgierz 603
Council Bluffs 573
Dublin 494
Moscow 455
Santa Clara 444
Medford 428
Beijing 392
Helsinki 385
Jacksonville 373
Palermo 356
Des Moines 347
Los Angeles 330
Altamura 318
Tokyo 317
Dallas 292
Ho Chi Minh City 284
Lauterbourg 267
Princeton 262
Lawrence 243
Nanjing 236
San Diego 235
New York 230
Frankfurt am Main 216
Hanoi 210
Milan 194
Hefei 181
Boardman 179
Dearborn 174
Chicago 173
São Paulo 145
Rome 136
Buffalo 131
London 128
Phoenix 114
Nuremberg 103
Tulsa 102
Abidjan 101
Ludwigshafen am Rhein 97
Nanchang 73
Boston 72
The Dalles 71
Atlanta 70
Changsha 69
Hebei 68
Orem 67
Shenyang 64
Jinan 56
San Paolo di Civitate 56
Washington 54
Tianjin 53
Bremen 51
Da Nang 51
Denver 49
Columbus 48
Lappeenranta 48
Seongnam 48
Brasília 46
Toronto 46
Zhengzhou 44
Brighton 43
Falls Church 43
Shanghai 43
Brussels 42
Montreal 42
Trieste 42
Brooklyn 41
Jiaxing 40
Saint Petersburg 39
Amsterdam 37
Chennai 37
Philadelphia 37
Quito 37
Rio de Janeiro 36
San Francisco 36
Warsaw 36
Guayaquil 34
Izmir 34
Munich 34
Naples 34
Tashkent 34
Guangzhou 33
Verona 33
Poplar 32
Vienna 32
Belo Horizonte 30
Stockholm 30
Ningbo 29
Kumar 28
Totale 32.633
Nome #
Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10(+) phenotype 855
ITTERO OSTRUTTIVO COME SINTOMO DI ESORDIO IN SOGGETTO CON LEUCEMIA MONOCITICA ACUTA. CASO CLINICO 371
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8 358
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 351
A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of haemolytic uremic syndrome 345
Pathobiology of Hodgkin lymphoma. 342
Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation 329
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions 329
Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients. 319
BIOCOMPATIBILITY AND BIODEGRADABILITY OF ELECTROSPUN PHEA-PLA SCAFFOLDS: OUR PRELIMINARY EXPERIENCE IN A MURINE ANIMAL MODEL 314
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis 306
CD4+CD25+ Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction 305
Microenvironment-centred dynamics in aggressive B-cell lymphomas. 304
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 302
Splenic marginal zone lymphoma with or without villous lymphocytes 292
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma 285
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 281
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. 278
C1q induces in vivo angiogenesis and promotes wound healing 271
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 264
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 262
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. 260
Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: two mixing fatal syndromes? 260
Mast Cells and Th17 Cells Contribute to the Lymphoma-Associated Pro-Inflammatory Microenvironment of Angioimmunoblastic T-Cell Lymphoma 258
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 258
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 258
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 258
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma 250
C1q Production by Bone Marrow Stromal Cells 250
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. 250
IFI16 expression is related to selected transcription factors during B-cell differentiation 250
Splenic marginal zone lymphoma: a prognostic model for clinical use. 249
C1q as a unique player in angiogenesis with therapeutic implication in wound healing 248
Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design 247
A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome 247
COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis 245
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL) 244
An automated image analysis methodology for classifying megakaryocytes in chronic myeloproliferative disorders 244
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. 243
Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis. 242
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. 242
T Cell Large Granular Lymphocytic Leukemia in Association with Sjógren's Syndrome 240
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma 240
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 240
The aryl hydrocarbon receptor modulates acute and late mast cell responses. 239
Angioimmunoblastic T-cell lymphoma 237
A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2. 234
Iron capture through CD71 drives perinatal and tumor-associated Treg expansion 233
Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities 232
The bone marrow stroma in hematological neoplasms-a guilty bystander. 229
Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation. 228
Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement 228
Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis. 226
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity 226
Osteopontin shapes immunosuppression in the metastatic niche 225
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 225
Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions. 223
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis 221
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 219
Use of intrapleural bortezomib in myelomatous pleural effusion [1] 218
Histological features and ki-67 Index in cervical atypical lesions 216
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 215
Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing 213
Mast cells infiltrating inflamed or transformed gut alternatively sustain mucosal healing or tumor growth 213
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 212
Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer 212
Direct RNA Nanopore Sequencing of SARS-CoV-2 Extracted from Critical Material from Swabs 211
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. 209
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. 209
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. 208
Deoxycoformycin (pentostatin) in the treatment of Splenic Marginal Zone Lymphoma (SMZL)with or without villous lymphocytes 207
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 207
Humoral immunotherapy of multiple myeloma: perspectives and perplexities 205
Antibody-Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non-small cell lung cancer subsequent to PD-1/PD-L1 blockade 205
miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of tumor cells in triple-negative breast cancer 204
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 203
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 203
MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases 203
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function 203
Presenting features and outcome of Splenic Marginal Zone Lymphoma with or without villous lymphocytes. A retrospective analysis in a Series of 145 Patients 201
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces 199
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies 198
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage hodgkin lymphoma in the pre-positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial 198
Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors. 197
Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis. 196
Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. 196
SOCS2 controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias 196
ATR expands embryonic stem cell fate potential in response to replication stress 196
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 195
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells 195
SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage. 195
Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers 195
Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth 194
A novel role of the CX(3)CR1/CX(3)CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. 192
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 191
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer 190
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk 190
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. 189
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment 189
TRABECTEDIN OVERRIDES OSTEOSARCOMA DIFFERENTIATIVE BLOCK AND REPROGRAMS THE TUMOR IMMUNE ENVIRONMENT ENABLING EFFECTIVE COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS 188
Totale 24.467
Categoria #
all - tutte 193.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.542 0 0 0 107 141 170 263 194 374 424 283 586
2022/20233.986 372 854 66 345 408 550 339 276 428 44 213 91
2023/20241.980 73 302 147 165 148 384 234 127 43 98 38 221
2024/20255.042 222 429 400 394 182 168 352 309 402 565 537 1.082
2025/202618.265 1.133 545 1.232 1.610 1.618 2.315 2.351 1.714 1.487 2.042 1.546 672
2026/20274.042 994 837 2.202 9 0 0 0 0 0 0 0 0
Totale 53.515